The safety and efficacy of bortezomib in relapsed multiple myeloma.

A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

The safety and efficacy of bortezomib in relapsed multiple myeloma.

Sundar Jagannath

Clin Adv Hematol Oncol

Multiple Myeloma Service and Bone Marrow and Blood Stem Cell Transplantation Center, Saint Vincent's Comprehensive Cancer Center, New York City, NY, and New York Medical College, USA.

Published: May 2006

Download full-text PDF
Source

Publication Analysis

Top Keywords

safety efficacy

efficacy bortezomib

bortezomib relapsed

relapsed multiple

multiple myeloma

safety

bortezomib

relapsed

multiple

myeloma

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!